Keros Therapeutics, Inc. (KROS) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Keros Therapeutics, Inc. (KROS) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

KROS Income Statement

Keros Therapeutics, Inc. (KROS) annual income statement — 8-year revenue, gross profit & net income history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	40.01M	0	367K	385K	14.26M	18.17M	211.25M	3.04M	388K	37K	83K	143K	8K	0	0	0	0	0	0	20M
Revenue Growth %	180.53%	-100%	-99.83%	-87.34%	3575.77%	49002.7%	-	2027.27%	4750%	-	-	-	-	-	-	-100%	-	-100%	-	-
Cost of Goods Sold	0	0	403K	400K	395K	370K	0	332K	314K	0	0	0	551K	0	0	0	0	0	0	302K
COGS % of Revenue	-	-	109.81%	103.9%	2.77%	2.04%	-	10.91%	80.93%	-	-	-	6887.5%	-	-	-	-	-	-	1.51%
Gross Profit	0	0	-36K	-17.43M	13.87M	17.8M	211.25M	2.71M	74K	37K	83K	143K	-543K	0	0	0	0	0	0	19.7M
Gross Margin %	-	-	-9.81%	-4526.49%	97.23%	97.96%	100%	89.09%	19.07%	100%	100%	100%	-6787.5%	-	-	-	-	-	-	98.49%
Gross Profit Growth %	-100%	-100%	-100.02%	-743.06%	18639.19%	48002.7%	-	1795.1%	113.63%	-	-	-	-	-	-	-100%	-	100%	-	-
Operating Expenses	27.19M	30.94M	25.84M	11.84M	29.25M	57.62M	59.21M	55.96M	58.73M	50.48M	48.57M	46.6M	42.74M	41.34M	38.87M	31.96M	27.98M	30.73M	24.13M	24.56M
OpEx % of Revenue	67.96%	-	7041.14%	3076.1%	205.1%	317.12%	28.03%	1839.71%	15136.86%	136421.62%	58513.25%	32586.01%	534212.5%	-	-	-	-	-	-	122.82%
Selling, General & Admin	6.7M	8.61M	10.15M	11.74M	10.13M	14.48M	10.5M	10.66M	9.82M	9.96M	10.31M	9.11M	8.6M	8.8M	7.78M	7.09M	6.94M	7.45M	6.05M	5.73M
SG&A % of Revenue	16.75%	-	2764.85%	3050.13%	71.01%	79.71%	4.97%	350.59%	2530.93%	26921.62%	12419.28%	6367.13%	107462.5%	-	-	-	-	-	-	28.66%
Research & Development	20.49M	22.33M	16.1M	17.91M	19.52M	43.5M	48.71M	45.63M	49.23M	40.52M	38.26M	37.49M	34.14M	32.53M	31.09M	24.87M	21.04M	23.28M	18.08M	18.83M
R&D % of Revenue	51.22%	-	4386.1%	4652.47%	136.86%	239.45%	23.06%	1500.03%	12686.86%	109500%	46093.98%	26218.88%	426750%	-	-	-	-	-	-	94.17%
Other Operating Expenses	0	0	-403K	-1000K	-395K	-370K	0	-332K	-314K	0	0	0	0	0	0	0	0	0	0	0
Operating Income	12.82M	-30.94M	-25.88M	-29.27M	-15.38M	-39.82M	152.04M	-53.25M	-58.66M	-50.44M	-48.48M	-46.45M	-43.28M	-41.34M	-38.87M	-31.96M	-27.98M	-30.73M	-24.13M	-4.87M
Operating Margin %	32.04%	-	-7050.95%	-7602.6%	-107.87%	-219.16%	71.97%	-1750.62%	-15117.78%	-136321.62%	-58413.25%	-32486.01%	-541000%	-	-	-	-	-	-	-24.33%
Operating Income Growth %	183.32%	22.3%	-117.02%	45.04%	73.77%	21.06%	413.59%	-14.64%	-35.53%	-22.02%	-24.73%	-45.35%	-54.7%	-34.53%	-61.11%	-556.8%	-38.52%	-97.72%	-53%	63.39%
EBITDA	12.82M	-30.54M	-25.47M	-28.87M	-14.99M	-39.45M	152.38M	-52.92M	-58.34M	-50.13M	-48.21M	-46.21M	-42.73M	-41.15M	-38.7M	-31.83M	-27.85M	-30.42M	-24.01M	-4.56M
EBITDA Margin %	32.04%	-	-6941.14%	-7498.7%	-105.1%	-217.12%	72.14%	-1739.71%	-15036.86%	-135494.59%	-58079.52%	-32313.29%	-534112.5%	-	-	-	-	-	-	-22.82%
EBITDA Growth %	185.52%	22.59%	-116.72%	45.45%	74.31%	21.32%	416.11%	-14.53%	-36.54%	-21.84%	-24.56%	-45.16%	-53.43%	-35.26%	-61.17%	-597.48%	-38.6%	-98.21%	-53.06%	65.47%
D&A (Non-Cash Add-back)	0	402K	403K	400K	395K	370K	344K	332K	314K	306K	277K	247K	551K	191K	167K	127K	126K	308K	113K	302K
EBIT	0	-28.71M	-23.71M	-24.98M	-8.7M	-32.92M	158.49M	-29.47M	-52.96M	-45.26M	-43.11M	-40.24M	-39.44M	-41.34M	-38.87M	-29.72M	-23.51M	-27.27M	-24.18M	-4.94M
Net Interest Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-1K	-1K
Interest Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1K	1K
Other Income/Expense	2.11M	2.23M	2.17M	4.29M	6.68M	6.9M	6.45M	7.53M	5.7M	5.18M	5.37M	6.21M	3.84M	3.83M	3.06M	2.24M	4.47M	3.46M	-60K	-75K
Pretax Income	14.93M	-28.71M	-23.71M	-24.98M	-8.7M	-32.92M	158.49M	-45.73M	-52.96M	-45.26M	-43.11M	-40.24M	-39.44M	-37.51M	-35.8M	-29.72M	-23.51M	-27.27M	-24.19M	-4.94M
Pretax Margin %	37.3%	-	-6459.95%	-6487.01%	-61.03%	-181.19%	75.03%	-1503.16%	-13648.45%	-122316.22%	-51944.58%	-28141.96%	-493000%	-	-	-	-	-	-	-24.7%
Income Tax	-772K	0	0	-1.51M	-1.42M	-2.22M	10.04M	300K	0	0	0	0	0	0	0	0	0	0	0	2M
Effective Tax Rate %	-5.17%	0%	0%	6.06%	16.36%	6.75%	6.34%	-0.66%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	-40.44%
Net Income	14.15M	-28.71M	-23.71M	-23.46M	-7.28M	-30.7M	148.45M	-46.03M	-52.96M	-45.26M	-43.11M	-40.24M	-39.44M	-37.51M	-35.8M	-29.72M	-23.51M	-27.27M	-24.19M	-6.94M
Net Margin %	35.37%	-	-6459.95%	-6093.77%	-51.04%	-168.96%	70.27%	-1513.02%	-13648.45%	-122316.22%	-51944.58%	-28141.96%	-493000%	-	-	-	-	-	-	-34.7%
Net Income Growth %	294.41%	6.47%	-115.97%	49.03%	86.25%	32.17%	444.32%	-14.37%	-34.27%	-20.67%	-20.42%	-35.42%	-67.77%	-37.55%	-48.04%	-328.21%	-15.82%	-74.54%	-52.26%	34.99%
Net Income (Continuing)	0	-28.71M	-23.71M	-23.46M	-7.28M	-30.7M	148.45M	-46.03M	-52.96M	-45.26M	-43.11M	-40.24M	-39.44M	-37.51M	-35.8M	-29.72M	-23.51M	-27.27M	-24.19M	-6.94M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	0.00	-1.45	-1.21	-0.86	-0.18	-0.76	3.62	-1.14	-1.47	-1.25	-1.46	-1.34	-1.33	-1.27	-1.15	-1.09	-0.75	-0.99	-1.01	-0.30
EPS Growth %	100%	-90.79%	-133.43%	24.56%	87.76%	39.2%	347.95%	14.93%	-10.53%	1.57%	-26.96%	-22.94%	-77.33%	-28.28%	-13.86%	-263.33%	13.79%	-47.76%	-48.53%	38.78%
EPS (Basic)	0.00	-1.45	-1.21	-0.86	-0.18	-0.76	3.66	-1.14	-1.47	-1.25	-1.46	-1.34	-1.33	-1.27	-1.15	-1.09	-0.75	-0.99	-1.01	-0.30
Diluted Shares Outstanding	0	19.8M	19.63M	27.2M	40.62M	40.61M	41.02M	40.34M	36.1M	36.1M	29.45M	30.13M	29.67M	29.6M	28.37M	27.33M	25.55M	24.05M	23.99M	23.44M
Basic Shares Outstanding	0	19.8M	19.63M	27.2M	40.62M	40.61M	40.56M	40.34M	36.1M	36.1M	29.45M	30.13M	29.67M	29.6M	28.37M	27.33M	25.55M	24.05M	23.99M	23.44M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-